Skip to content

Study · Not a test of the peptide alone · 2001

1 result

Biochemical and morphogenic effects of the interaction between protein kinase C-epsilon and actin in vitro and in cultured NIH3T3 cells.

Hernandez RM, Wescott GG, Mayhew MW, McJilton MA, Terrian DM

Journal of cellular biochemistry1 Jan 2001Cited by 16 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Mechanism

    In a cell-free system, protein kinase C-epsilon was capable of desequestering actin monomers from physiologically relevant concentrations of thymosin beta4.

    In plain wordsIn lab tests, protein kinase C-epsilon freed actin that Tbeta4 had been holding. The result is about the kinase.

    Outcome
    Not applicableDesequestering of actin monomers from Tbeta4 by protein kinase C-epsilon
    Study

    n: not reported in source

    Cell-free actin system
    Outcome group
    Receptor activity and mechanism · Whole body

    Source sentences

    Summary
    Studies with a cell-free system suggest that protein kinase C-epsilon inhibits the in vitro disassembly of actin filaments, is capable of desequestering actin monomers from physiologically relevant concentrations of thymosin beta4

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.